US court says Samsung must pay Apple $539 million in patent lawsuit

A US court has said that Samsung ought to pay Apple $539 million for violating intellectual property rights of the latter. The Samsung vs. Apple patent infringement case started in 2011.

Reports in the US point out that Samsung was found liable in the initial verdict in 2012 and was initially asked to pay over $1 billion to Apple but the amount was later reduced in further court hearings. Under the US patent law, infringement of a design patent can result in a plaintiff receiving total profits made through the product.

Samsung`s lawyers appealed the case, bringing down the compensation of $1 billion to $400 million in 2015 at the US Court of Appeals for the Federal Circuit.

This time, a jury in a northern California US district court in San Jose deliberated for five days to decide the fresh penalty in a case that alleged that Samsung`s Android handsets used design elements stolen from the iPhone maker.

“We`re grateful to the jury for their service and pleased they agree that Samsung should pay for copying our products,” Apple said in a statement.

“This case has always been about more than money. Apple ignited the smartphone revolution with iPhone and it is a fact that Samsung blatantly copied our design. It is important that we continue to protect the hard work and innovation of so many people at Apple,” the statement said.

Samsung, however, was displeased with the verdict.

“Today`s decision flies in the face of a unanimous Supreme Court ruling in favoor of Samsung on the scope of design patent damages,” Samsung said in its statement.

“We will consider all options to obtain an outcome that does not hinder creativity and fair competition for all companies and consumers,” reported The Registrar, quoting the statement from the South Korean giant.

About Erica Smith

With majors in industrial finance, Erica took to journalism because of her interest in writing. Having keen interest in medical industry as well, Erica has a unique perspective on the health industries.

View all posts by Erica Smith →